These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Differentiation between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular diseases by comparison of the ratio of OKT4+ cells and OKT8+ cells in BALF T lymphocytes. Nagai S; Fujimura N; Hirata T; Izumi T Eur J Respir Dis; 1985 Jul; 67(1):1-9. PubMed ID: 3876946 [TBL] [Abstract][Full Text] [Related]
43. Spectrum and diagnosis of idiopathic pulmonary fibrosis. Maheshwari U; Gupta D; Aggarwal AN; Jindal SK Indian J Chest Dis Allied Sci; 2004; 46(1):23-6. PubMed ID: 14870865 [TBL] [Abstract][Full Text] [Related]
45. Pathophysiology of diffuse interstitial lung disease. Stinson JM J Natl Med Assoc; 1974 Jul; 66(4):296-7 passimass. PubMed ID: 4603083 [No Abstract] [Full Text] [Related]
46. Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Peckham RM; Shorr AF; Helman DL Respiration; 2004; 71(2):165-9. PubMed ID: 15031572 [TBL] [Abstract][Full Text] [Related]
47. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):646-64. PubMed ID: 10673212 [No Abstract] [Full Text] [Related]
48. Corticosteroids in idiopathic pulmonary fibrosis. Lynch JP; White E; Flaherty K Curr Opin Pulm Med; 2001 Sep; 7(5):298-308. PubMed ID: 11584180 [TBL] [Abstract][Full Text] [Related]
51. [Diagnostic value of secretory products of eosinophils and neutrophils in bronchoalveolar lavage in patients with idiopathic lung fibrosis]. Pohl WR; Schenk E; Umek H; Micksche M; Kummer F; Köhn H Wien Klin Wochenschr; 1993; 105(14):387-92. PubMed ID: 8396288 [TBL] [Abstract][Full Text] [Related]
52. The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis. Manali ED; Stathopoulos GT; Kollintza A; Kalomenidis I; Emili JM; Sotiropoulou C; Daniil Z; Roussos C; Papiris SA Respir Med; 2008 Apr; 102(4):586-92. PubMed ID: 18162388 [TBL] [Abstract][Full Text] [Related]
53. Microscopic polyangiitis presenting as a "pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis? Birnbaum J; Danoff S; Askin FB; Stone JH Arthritis Rheum; 2007 Jun; 56(6):2065-71. PubMed ID: 17530647 [TBL] [Abstract][Full Text] [Related]
54. [The role of pulmonary rehabilitation in idiopathic pulmonary fibrosis]. Vainshelboim B; Kramer MR Harefuah; 2012 Apr; 151(4):220-4, 253. PubMed ID: 22616150 [TBL] [Abstract][Full Text] [Related]
55. Effect of prolonged low-dose methylprednisolone therapy in acute exacerbation of idiopathic pulmonary fibrosis. Nishiyama O; Shimizu M; Ito Y; Kume H; Suzuki R; Yokoi T; Yamaki K Respir Care; 2001 Jul; 46(7):698-701. PubMed ID: 11403701 [TBL] [Abstract][Full Text] [Related]
59. Recent advances in particulate-induced pulmonary fibrosis; for the application of possible strategy experimentally and clinically. Kim KA; Park CY; Lim Y; Lee KH Curr Drug Targets; 2000 Nov; 1(3):297-307. PubMed ID: 11465077 [TBL] [Abstract][Full Text] [Related]